New combo therapy aims to tame rare artery disease
NCT ID NCT02902731
First seen Apr 02, 2026 · Last updated May 12, 2026 · Updated 6 times
Summary
This study tested whether adding anakinra (a drug that blocks inflammation) to standard steroid treatment could lower relapse rates in people with giant cell arteritis, a disease that causes swollen arteries. About 30 adults aged 50 and older were enrolled, but the trial was stopped early. The goal was to see if the combination could reduce the need for long-term steroids and their side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GIANT CELL ARTERITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Pr Aouba
Caen, 14000, France
Conditions
Explore the condition pages connected to this study.